Quest Diagnostics has introduced a new pharmacogenomic (PGx) laboratory testing service designed to assist healthcare providers in understanding their patients' genetic responses to specific ...

Overall Drug Positivity Holds Steady at Historically High Rates while Marijuana Positivity Continued Upward Climb in the General U.S. Workforce Marijuana Positivity in the General U.S. Workforce ...

Overall Drug Positivity Holds Steady at Historically High Rates while Marijuana Positivity Continued Upward Climb in the General U.S. Workforce Marijuana Positivity in the General U.S. Workforce ...

The rate of substituted or invalid drug tests — an indication of tampering to hide drug use — rose more than six-fold in 2023 versus the prior year, according to a Quest Diagnostics analysis of 9.8 ...

SECAUCUS, N.J. - Quest Diagnostics (NYSE:DGX), a $20.2 billion healthcare diagnostics leader currently trading near its 52-week high at $179.88, announced Thursday the launch of a new pharmacogenomic ...

SECAUCUS, N.J., Sept. 2, 2025 /PRNewswire/ -- The percentage of employees in the general U.S. workforce testing positive for fentanyl in random drug tests far exceeded those in pre-employment testing, ...

SECAUCUS, N.J., May 18, 2023 /PRNewswire/ -- The percentage of employees in the general U.S. workforce testing positive for marijuana following an on-the-job accident increased to its highest level in ...

The Quest Diagnostics white paper, "Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing", offers an in-depth analysis of the current state of rare disease diagnostics ...

Drug Abuse Testing Market is expected to reach US$ 12.77 billion in 2033 from US$ 6.64 billion in 2024, with a CAGR of 7.54% from 2025 to 2033. Rising drug abuse rates, growing public awareness, more ...